Searched for
CONCORD BIOTECH STOCKS
Two Trades for Today: A maker of forged components for a 7.7% gain, a mid-cap pharma stock for a 6% upmoveOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian equities lost momentum after a positive start, with Nifty closing lower and broader markets declining sharply. Investor caution ahea...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian equities ended higher on Tuesday, supported by easing geopolitical tensions and softer crude prices. A sharp drop in India VIX boost...
- Concord Biotech shares jump 8% on USFDA nod for Mycophenolate Mofetil oral suspensionConcord Biotech shares saw a significant jump on Wednesday. This surge followed the company's announcement of receiving approval from the U...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian benchmark indices ended higher after a volatile session, with late buying in heavyweight IT stocks lifting sentiment. Sensex gained ...
- Forget the noise: These 54 smallcap stocks attracted FII buying in March quarterForeign institutional investors are strategically buying into beaten-down smallcap stocks in India, increasing stakes in 54 companies despi...
- Concord Biotech shares tumble 16% after weak Q3 earningsConcord Biotech shares fell 16% to Rs 1,777.7 after the company reported a 2.1% YoY decline in Q3 FY25 net profit to Rs 75.92 crore, despit...
- Stock Radar: 50% rally in 1 year; wait for confirmation of rounding bottom pattern to go long in Concord BiotechConcord Biotech Ltd's stock, after reaching record highs, is poised for a breakout from a Rounding Bottom pattern. Experts suggest a close ...
- Concord Biotech stock slips over 5% after Rs 519 crore worth of shares change handsShares of Concord Biotech fell 5.3% on BSE due to a large block deal where Ontario Inc. sold a 3.4% stake at a discount, impacting stock pe...
- Hot Stocks: Jefferies upgrades JSW Steel, Motilal Oswal sees over 20% upside in Lemon TreeThe global investment bank maintained a buy rating on Coal India but raised the target price to Rs 450 from Rs 425 earlier.
- Concord Biotech's niche strengths seen buoying earnings: AnalystsShares of the Ahmedabad-based biopharma company, which listed a few weeks ago at a more than 20% premium, have notched another 9% gain sinc...
- Concord Biotech shares list at a healthy premium. What should investors do?Concord Biotech is a biotechnology company and a leading maker of select fermentation-based APIs across immunosuppressants and oncology in ...
- Concord Biotech shares list at 21% premium over IPO priceConcord Biotech is a biotechnology company and a leading maker of select fermentation-based APIs across immunosuppressants and oncology in ...
- Stocks in news: Nykaa, HDFC AMC, Concord Biotech, JSW Steel, Adani EnergyNykaa, HDFC AMC, Indus Towers, Page Industries and ACC have been excluded from Nifty Next50 in the latest revision of various NSE indices.
- Concord Biotech to list on Friday. Here’s what GMP suggestsAnalysts are of the opinion that a market premium of over 15% on the issue price is justified based on the company's business model, which ...
- Concord Biotech IPO share allotment likely today. Here's how you can check statusOn the allotment date, investors get to know about the number of shares allotted to them as against the bids made. They can check the allot...
- SBFC Finance vs Concord Biotech: Which IPO should you pick?The issue of SBFC Finance comprises fresh equity issue of Rs 600 crore and an offer for sale (OFS) of Rs 425 crore, while Concord Biotech i...
- Jhunjhunwala-backed Concord Biotech sets IPO price band at Rs 705-741According to the draft papers, Concord Biotech's IPO is entirely an offer for sale of (OFS) of 2,09,25,652 equity shares by Helix Investmen...
- Concord Biotech plans overseas foray, invest $20 millionAhmedabad-based Concord Biotech will invest $20 million in setting up a fermentation facility abroad to save on power and fuel costs.
- Mylan sells stake in Concord BiotechWorld’s second-largest generic drug maker Mylan, which held a majority stake in Ahmedabad-based Concord Biotech through its subsidiary Matr...
Load More
